Categories
Change Password!
Reset Password!
Given the lack of studies involving the ideal low‐intensity shockwave therapy (LiST) procedure in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), this randomized controlled, parallel-group, two-arm study aimed to compare the safety and efficacy of 6 LiST sittings used once or twice per week for the treatment of CP/CPPS.
The use of 6 sessions
of low‐intensity shockwave therapy used once per week for 6 weeks or 2 times
per week for 3 weeks was found to have comparable efficacy and safety for the
treatment of chronic prostatitis/chronic pelvic pain syndrome.
Given the lack of
studies involving the ideal low‐intensity shockwave therapy (LiST) procedure in
patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), this
randomized controlled, parallel-group, two-arm study aimed to compare the
safety and efficacy of 6 LiST sittings used once or twice per week for the
treatment of CP/CPPS.
A total of 50 patients with CPPS type IIIb were randomly assigned to two groups: Group A (25 patients) with 6 LiST sessions once weekly or; Group B (25 patients) with 6 LiST sessions twice-weekly (Group B, n = 25).
Similar therapy practices concerning the application of LiST,
impulses (5000 per session), energy flux density (0.096 mJ/mm2), and
frequency were used. Assessments were done at follow-up of 1 month and 3
months.
In both groups, LiST considerably improved National
Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI), pain and
quality of life scores, along with International Index of Erectile
Function-Erectile Domain at the follow-up. No profound differences were
witnessed between both groups at follow-up. There were no adverse events and
dropouts.
Six sittings of LiST used once or twice a week seem to have
similar outcomes concerning its safety and efficacy in CP/CPPS patients. Future studies are important, as LiST slowly
gains its place for CP/CPPS management.
The Prostate
Comparing two different low-intensity shockwave therapy frequency protocols for nonbacterial chronic prostatitis/chronic pelvic pain syndrome: A two-arm, parallel-group randomized controlled trial
Ioannis Mykoniatis et al.
Comments (0)